Shares of InspireMD Inc (NYSEAMERICAN:NSPR) gapped down prior to trading on Friday . The stock had previously closed at $3.70, but opened at $2.60. InspireMD shares last traded at $1.49, with a volume of 3,470,148 shares changing hands.
Separately, HC Wainwright restated a “buy” rating and issued a $5.00 target price on shares of InspireMD in a report on Monday, August 19th.
InspireMD (NYSEAMERICAN:NSPR) last released its earnings results on Tuesday, August 6th. The medical equipment provider reported ($1.59) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($2.00) by $0.41. The firm had revenue of $1.35 million during the quarter, compared to analysts’ expectations of $1.30 million.
An institutional investor recently bought a new position in InspireMD stock. Bank of New York Mellon Corp bought a new position in shares of InspireMD Inc (NYSEAMERICAN:NSPR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 23,946 shares of the medical equipment provider’s stock, valued at approximately $82,000. Bank of New York Mellon Corp owned approximately 1.76% of InspireMD as of its most recent SEC filing.
InspireMD Company Profile (NYSEAMERICAN:NSPR)
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.
See Also: Trade Deficit
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.